Prostate Cancer Clinical Trials

Showing 21-40 of 1,222 trials

CARE Tool Study Aim 3

NCT07296887

This study is a multi-site randomized trial to study the implementation of the CARE Tool and evaluate the CARE Tool. The CARE Tool is a web-based tool that gives people information about cancer care costs, health insurance, and resources to help with costs. Overall, the study aims to help patients with cancer overcome barriers they face navigating insurance and accessing financial resources.

Gynecologic CancerProstate CancerLung Cancer+1 more

Washington University School of Medicine430 participantsStarted Apr 2026

Alton, Illinois, United States • Rolla, Missouri, United States • St Louis, Missouri, United States

ACTIVE_NOT_RECRUITINGNA

Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial

NCT05918263

The purpose of this study is to determine whether a 16-week, home-based, virtually supervised exercise program will slow cancer progression of prostate cancer among Black men with prostate cancer undergoing active surveillance. The name of the study intervention involved in this study is: Aerobic high-intensity interval training (HIIT) (training exercise intervention)

Prostate CancerProstatic Neoplasms

Dana-Farber Cancer Institute68 participantsStarted Jan 2024

Boston, Massachusetts, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States

CARE Tool Study Aim 3

Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial

Related Searches

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial

PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer

MRI Guided SBRT for Localized Prostate Cancer

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Michigan Genetic Hereditary Testing (MiGHT)

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Timing of Post-prostatectomy PSMA Imaging

A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC

A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments